COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers
LONDON, June 03, 2021 -- COMPASS Pathways plc (Nasdaq: CMPS) (βCOMPASSβ), a mental health care company dedicated to accelerating patient access to evidence-base... Read More...